Anti-CD9 Monoclonal Antibody Activates p72syk in Human Platelets (*)

NNKY 1-19, anti-CD9 monoclonal antibody (MoAb), induced protein tyrosine phosphorylation of 125-, 97-, 75-, 64-, and 40-kDa proteins in human platelets, whereas F(ab′)2 fragments of NNKY 1-19 did not, suggesting that the stimulation of FcγII receptors is required for the induction of protein tyrosine phosphorylation. Tyrosine-phosphorylated proteins of 97 and 125 kDa were associated with aggregation, while NNKY 1-19-induced protein tyrosine phosphorylation was completely inhibited by prostaglandin I2 (PGI2). The activity of p72syk was assessed in immunoprecipitation kinase assays to determine at which step the signal transduction pathway leading to protein tyrosine phosphorylation was suspended. NNKY 1-19 induced a rapid and transient increase in the p72syk-associated tyrosine kinase activity that peaked at 10 s and subsided to the original level 2 min after stimulation. Coinciding with this time course, p60c-src transiently associated with p72syk. In platelets preexposed to GRGDS peptides or PGI2, NNKY 1-19 also increased the p72syk-associated tyrosine kinase activity and led to the association of p60c-src with p72syk. However, in contrast to the control without any inhibitor, the elevated tyrosine kinase activity and the associated state of the two tyrosine kinases persisted as long as 5 min after stimulation. F(ab′)2 fragments of NNKY 1-19 induced changes similar to those observed with the effects of GRGDS peptides or PGI2 treatment on intact IgG NNKY 1-19 stimulation. F(ab′)2 fragments of another CD9 MoAb, PMA2, had effects on p72sykessentially similar to those of NNKY 1-19. These findings suggest that the binding of anti-CD9 MoAb to CD9 on the platelet membrane per se induces an increase in the p72syk-associated tyrosine kinase activity but that FcγII receptor-mediated signal(s) is required for the full activation of platelets and the appearance of tyrosine-phosphorylated proteins. The elevated intracellular cAMP level induced by PGI2 acts at a step distal to the activation of p72syk and inhibited the signal transduction pathway leading to protein tyrosine phosphorylation and aggregation. p72sykactivation occurs in the absence of aggregation, but aggregation appears to reduce the elevated p72syk activity induced by anti-CD9 MoAb.

[1]  J. Bolen,et al.  Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RI , 1995, Molecular and cellular biology.

[2]  Y. Tohyama,et al.  Translocation, activation and association of protein-tyrosine kinase (p72syk) with phosphatidylinositol 3-kinase are early events during platelet activation. , 1994, European journal of biochemistry.

[3]  S. Greenberg,et al.  Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. , 1994, The Journal of biological chemistry.

[4]  H. Yamamura,et al.  Protein-tyrosine kinase p72syk is activated by thromboxane A2 mimetic U44069 in platelets. , 1993, Biochemical and biophysical research communications.

[5]  N. Ryba,et al.  Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation. , 1993, The Journal of biological chemistry.

[6]  K. Robbins,et al.  Involvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling. , 1993, The Journal of biological chemistry.

[7]  Y. Yatomi,et al.  Anti‐CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4,5‐bisphosphate hydrolysis, phosphatidylinositol 3,4‐bisphosphate synthesis, and protein‐tyrosine phosphorylation in human platelets , 1993, FEBS letters.

[8]  H. Yamamura,et al.  Association with B-cell-antigen receptor with protein-tyrosine kinase p72syk and activation by engagement of membrane IgM. , 1993, European journal of biochemistry.

[9]  E. Salzman,et al.  Membrane glycoproteins and platelet cytoskeleton in immune complex-induced platelet activation. , 1993, Blood.

[10]  J. Brugge,et al.  Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets , 1993, Molecular and cellular biology.

[11]  H. Kitagawa,et al.  Protein-tyrosine kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ mobilization in platelets. , 1993, The Journal of biological chemistry.

[12]  J. Papkoff,et al.  Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein. , 1992, Oncogene.

[13]  J. Parsons,et al.  Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets , 1992, The Journal of cell biology.

[14]  T. Yomo,et al.  The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin- sensitive cells , 1992, The Journal of cell biology.

[15]  H. Yamamura,et al.  Protein-tyrosine kinase p72syk is activated by wheat germ agglutinin in platelets. , 1992, Biochemical and biophysical research communications.

[16]  J. Hoxie,et al.  Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII. , 1992, The Journal of biological chemistry.

[17]  J. Barnwell,et al.  Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Plantavid,et al.  Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. , 1991, The Journal of biological chemistry.

[19]  J. Kelton,et al.  Investigation of the mechanisms of monoclonal antibody-induced platelet activation , 1991 .

[20]  Y. Yatomi,et al.  Two-step mobilization of arachidonic acid in platelet activation induced by low concentrations of TP 82, a monoclonal antibody against CD9 antigen. , 1991, European journal of biochemistry.

[21]  C. Boucheix,et al.  Molecular cloning of the CD9 antigen. A new family of cell surface proteins. , 1991, The Journal of biological chemistry.

[22]  J. Brugge,et al.  Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins , 1990, The Journal of cell biology.

[23]  G. Anderson,et al.  Signal transduction by the platelet Fc receptor. , 1990, Blood.

[24]  Chi‐Kuang Huang,et al.  Elevation of cAMP, but not cGMP, inhibits thrombin-stimulated tyrosine phosphorylation in human platelets. , 1990, Biochemical and biophysical research communications.

[25]  R. Klausner,et al.  Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Demos,et al.  Erbstatin blocks platelet activating factor‐induced protein‐tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets , 1990, FEBS letters.

[27]  L. Jennings,et al.  The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies. , 1990, The Journal of biological chemistry.

[28]  H. Okuda,et al.  Induction of platelet Ca2+ influx and mobilization by a monoclonal antibody to CD9 antigen. , 1990, Blood.

[29]  R. Carroll,et al.  Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein. , 1990, Biochemical Journal.

[30]  R. Carroll,et al.  Platelet activation by CD9 monoclonal antibodies is mediated by the FCγII receptor , 1990 .

[31]  J. Slupsky,et al.  Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. , 1989, The Journal of biological chemistry.

[32]  H. Yamamura,et al.  Thrombin and collagen induce rapid phosphorylation of a common set of cellular proteins on tyrosine in human platelets. , 1989, The Journal of biological chemistry.

[33]  R. Fagard,et al.  High pp60c-src level in human platelet dense bodies. , 1989, Blood.

[34]  J. Brugge,et al.  Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[36]  C. Soria,et al.  Mechanisms of the mAb ALB6(CD9) induced human platelet activation: comparison with thrombin. , 1987, Biochemical and biophysical research communications.

[37]  I. Bernstein,et al.  Leukocyte Typing II , 1986, Springer New York.

[38]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[39]  S. Kume,et al.  A monoclonal anti-human platelet antibody: a new platelet aggregating substance. , 1985, Blood.

[40]  A. Nisonoff,et al.  Preparation of F(ab')2 fragments from mouse IgG of various subclasses. , 1983, Journal of immunological methods.

[41]  P. Henson,et al.  Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. , 1973, The Journal of clinical investigation.